Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide maintenance: the SURMOUNT-4 evidence The SURMOUNT-4 trial used a randomized-withdrawal design: all participants took open-label tirzepatide for 36 weeks (reaching a mean weight reduction of about 20.9%), then were randomized either to continue the drug or switch to placebo for another 52 weeks
[DOI] [PubMed] [Google Scholar] 54.Qualmann C, Nauck MA, Holst JJ, rskov C, Creutzfeldt W
Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations
alopecia areata An autoimmune condition that causes the immune system to attack hair follicles
US$ 24.56
US$ 20.91
US$ 20.94
